HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dyck, P. J. Articles by Lambert, E. H. Search for Related Content PubMed PubMed Citation Articles by Dyck, P. J. Articles by Lambert, E. H.

Longitudinal study of neuropathic deficits and nerve conduction abnormalities in hereditary motor and sensory neuropathy type 1

Peripheral Neuropathy Research Laboratory, Mayo Clinic and Mayo Foundation, Rochester, MN. Dr. Lambert is an emeritus member of the Department of Neurology.

We measured neuropathic deficit (neurologic disability score [NDS]) and attributes of nerve conduction in hereditary motor and sensory neuropathy (HMSN 1) in cross-sectional evaluation of 69 patients and in longitudinal evaluation over approximately 15 years in 31 of them. Neuropathic deficit worsened by 0.6 NDS point per year in patients 5 to 14 years old at first evaluation, by 1.1 points in patients 15 to 39 years old, and by 0.9 point in patients 40 or more years old. Neuropathic deficit was greater in HMSN 1b (the disorder linked to Duffy) than in HMSN la (not linked to Duffy). Nerve conduction attributes changed significantly depending on attribute studied, age, and nerve. In patients evaluated serially, ulnar conduction velocity (CV) increased by a few meters per second in patients who were 5 to 14 or 15 to 39 years old at first examination, but decreased in patients who were older. In serial measurements, peroneal nerve amplitude decreased in all 3 age groups. We found an association between CV and amplitude or NDS at first and last examinations, suggesting an association between severity of the CV abnormality and neuropathic deficit. The severity of the CV abnormality in the young appears to predict later neurologic abnormality.

Address correspondence and reprint requests to Dr. Dyck, Mayo Clinic, 200 First Street SW, Rochester, MN 55905.

Received March 20, 1989. Accepted for publication in final form April 18, 1989.

This article has been cited by other articles:

				J Berciano, E Gallardo, A Garcia, J Infante, I Mateo, and O Combarros Charcot-Marie-Tooth disease type 1A duplication with severe paresis of the proximal lower limb muscles: a long-term follow-up study J. Neurol. Neurosurg. Psychiatry, October 1, 2006; 77(10): 1169 - 1176. [Abstract] [Full Text] [PDF]

				E. Gallardo, A. Garcia, O. Combarros, and J. Berciano Charcot-Marie-Tooth disease type 1A duplication: spectrum of clinical and magnetic resonance imaging features in leg and foot muscles Brain, February 1, 2006; 129(2): 426 - 437. [Abstract] [Full Text] [PDF]

				P. J. Dyck, P. C. O'Brien, W. J. Litchy, C. M. Harper, C. J. Klein, and P. J. B. Dyck Monotonicity of Nerve Tests in Diabetes: Subclinical nerve dysfunction precedes diagnosis of polyneuropathy Diabetes Care, September 1, 2005; 28(9): 2192 - 2200. [Abstract] [Full Text] [PDF]

				H Koike, M Hirayama, M Yamamoto, H Ito, N Hattori, F Umehara, K Arimura, S Ikeda, Y Ando, M Nakazato, et al. Age associated axonal features in HNPP with 17p11.2 deletion in Japan J. Neurol. Neurosurg. Psychiatry, August 1, 2005; 76(8): 1109 - 1114. [Abstract] [Full Text] [PDF]

				X. Yin, G. J. Kidd, E. P. Pioro, J. McDonough, R. Dutta, M. L. Feltri, L. Wrabetz, A. Messing, R. M. Wyatt, R. J. Balice-Gordon, et al. Dysmyelinated Lower Motor Neurons Retract and Regenerate Dysfunctional Synaptic Terminals J. Neurosci., April 14, 2004; 24(15): 3890 - 3898. [Abstract] [Full Text] [PDF]

				N. Hattori, M. Yamamoto, T. Yoshihara, H. Koike, M. Nakagawa, H. Yoshikawa, A. Ohnishi, K. Hayasaka, O. Onodera, M. Baba, et al. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients Brain, January 1, 2003; 126(1): 134 - 151. [Abstract] [Full Text] [PDF]

				G Pfeiffer, E M Wicklein, T Ratusinski, L Schmitt, and K Kunze Disability and quality of life in Charcot-Marie-Tooth disease type 1 J. Neurol. Neurosurg. Psychiatry, April 1, 2001; 70(4): 548 - 550. [Abstract] [Full Text] [PDF]

				S. Sancho, J. P. Magyar, A. Aguzzi, and U. Suter1 Distal axonopathy in peripheral nerves of PMP22-mutant mice Brain, August 1, 1999; 122(8): 1563 - 1577. [Abstract] [Full Text] [PDF]

				C. Bouchard, C. Lacroix, V. Plante, D. Adams, F. Chedru, J.-M. Guglielmi, and G. Said Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy Neurology, February 1, 1999; 52(3): 498 - 498. [Abstract] [Full Text] [PDF]